Aesthetic Medical Hldngs Group PE Ratio 2019-2023 | PAIYY
Current and historical p/e ratio for Aesthetic Medical Hldngs Group (PAIYY) from 2019 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Aesthetic Medical Hldngs Group PE ratio as of June 20, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Aesthetic Medical Hldngs Group PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-20 | 0.33 | 0.00 | |
| 2023-06-30 | 1.05 | $-0.27 | 0.00 |
| 2023-03-31 | 1.23 | $-0.25 | 0.00 |
| 2022-12-31 | 1.29 | $-0.27 | 0.00 |
| 2022-09-30 | 1.77 | $-0.81 | 0.00 |
| 2022-06-30 | 2.13 | $-0.69 | 0.00 |
| 2022-03-31 | 1.62 | $-1.07 | 0.00 |
| 2020-12-31 | 5.27 | $-1.56 | 0.00 |
| 2020-09-30 | 4.26 | $-2.67 | 0.00 |
| 2020-06-30 | 6.18 | $-2.67 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.020B | $0.096B |
| Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye and nose surgery, breast augmentation, liposuction and non-surgical aesthetic treatments. Aesthetic Medical International Holdings Group Limited is based in Shenzhen, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.556B | 15.38 |
| Cencora (COR) | United States | $47.310B | 18.44 |
| ICON (ICLR) | Ireland | $26.285B | 24.82 |
| DiDi Global (DIDIY) | China | $21.823B | 0.00 |
| Avantor (AVTR) | United States | $14.665B | 21.59 |
| CochLear (CHEOY) | Australia | $14.459B | 0.00 |
| Natera (NTRA) | United States | $13.261B | 0.00 |
| Revvity (RVTY) | United States | $13.239B | 23.22 |
| Medpace Holdings (MEDP) | United States | $12.486B | 41.08 |
| Viatris (VTRS) | United States | $11.966B | 3.58 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.394B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.807B | 20.69 |
| Solventum (SOLV) | United States | $9.209B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.426B | 0.00 |
| HealthEquity (HQY) | United States | $7.373B | 47.34 |
| Organon (OGN) | United States | $5.233B | 4.96 |
| Bausch + Lomb (BLCO) | Canada | $5.186B | 20.76 |
| Doximity (DOCS) | United States | $5.110B | 35.79 |
| PACS (PACS) | United States | $4.461B | 0.00 |
| Life Times (LTH) | United States | $3.655B | 38.29 |
| Sotera Health (SHC) | United States | $3.210B | 15.75 |
| Surgery Partners (SGRY) | United States | $3.184B | 29.13 |
| GoodRx Holdings (GDRX) | United States | $3.062B | 116.57 |
| Agilon Health (AGL) | United States | $2.772B | 0.00 |
| Progyny (PGNY) | United States | $2.450B | 42.18 |
| NovoCure (NVCR) | Jersey | $2.092B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.996B | 7.91 |
| Premier (PINC) | United States | $1.906B | 8.15 |
| BrightSpring Health Services (BTSG) | United States | $1.802B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.711B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.444B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.197B | 0.00 | |
| CareDx (CDNA) | United States | $0.733B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.721B | 0.00 |
| Embecta (EMBC) | United States | $0.719B | 4.89 |
| Pediatrix Medical (MD) | United States | $0.649B | 6.88 |
| Auna S.A (AUNA) | Luxembourg | $0.592B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| InnovAge Holding (INNV) | United States | $0.575B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.435B | 43.40 |
| ModivCare (MODV) | United States | $0.381B | 7.12 |
| Sonida Senior Living (SNDA) | United States | $0.379B | 0.00 |
| LifeMD (LFMD) | United States | $0.327B | 0.00 |
| DocGo (DCGO) | United States | $0.318B | 17.39 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| MultiPlan (MPLN) | United States | $0.246B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.237B | 0.00 |
| Beauty Health (SKIN) | United States | $0.223B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| So-Young (SY) | China | $0.107B | 51.51 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.88 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| Oncology Institute (TOI) | United States | $0.030B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.001B | 0.00 |